銆€銆€1. Li, H., et al., Dual MMP7-Proximity-Activated and Folate Receptor-Targeted Nanoparticles for siRNA Delivery, Biomacromolecules, 2015, 16 (1), p. 192–201.
銆€銆€2. Yu, W., et al., PEGylated recombinant human interferon-ω as a long-acting antiviral agent: Structure, antiviral activity and pharmacokinetics. Antiviral Research, 2014, 108, p. 142-147.
銆€銆€3. Fang, L., et al., Rational design, preparation, and characterization of a therapeutic enzyme mutant with improved stability and function for cocaine detoxification. ACS chemical biology, 2014, 9(8), 1764-72.
銆€銆€4. Fang, L., Computational Modeling, Design, And Characterization Of Cocainemetabolizing Enzymes For Anticocaine Medication, UKY, 2013, 39.
銆€銆€5. Resch, G., P. Moreillon, and V.A. Fischetti, PEGylating a bacteriophage endolysin inhibits its bactericidal activity. AMB Express, 2011, 1(29), p. 1-5.
銆€銆€6. Narasimhan, D., et al., Subunit Stabilization and Polyethylene Glycolation of Cocaine Esterase Improves In Vivo Residence Time, Mol Pharmacol, 2011, 80:1056–1065.
銆€銆€7. Park, J.-B., et al., PEGylation of bacterial cocaine esterase for protection against protease digestion and immunogenicity, Journal of Controlled Release, 2010, 142(2), p. 174-179.